Fineotex Chemical Ltd
Fineotex Chemical Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. Fineotex Chemicals anticipates strong revenue and profit growth driven by expanded Texas facility capacity and healthy demand in the U.S.
From Fineotex Chemical Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. INR 1,000 crores in FY'26.
- The company expects organic growth aided by sustainability trends and replication of product lines in global markets.
- Texas plant has expanded capacity to 1,48,000 MTPA with current utilization around 63-65%; plans to increase utilization to peak in coming quarters.
- Potential exists to double production by running two shifts with minimal additional capex (~USD 1-2 million).
- Growth driven by increasing wallet share in oil & gas markets across USA, Canada, Venezuela, Gulf countries, Saudi Arabia, and new markets like Suriname and Guyana.
- Textile business expected to recover from seasonal dips; moderate growth aligned with 5-7% industry CAGR.
2 more points from Fineotex Chemical Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Fineotex Chemical Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Fineotex Chemicals invested significantly in expanding its Texas facility, adding 69,000 MTPA capacity, increasing total capacity to 268,000 MTPA, enhancing ability to serve larger customer contracts and drive growth.
- The CrudeChem Group acquisition provided growth capital enabling capacity expansion and ramp-up; additional minor capex of USD 1-2 million anticipated for doubling shifts or enhancing capacity.
- Company remains cash disciplined with high cash on book and continues to monitor for selective inorganic growth opportunities with focus on synergy and value.
- Further capital infusion helped secure better pricing from suppliers, improving EBITDA margins.
- No major capex concerns currently; incremental capital investments are relatively small compared to growth potential.
2 more points from Fineotex Chemical Ltd's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Fineotex Chemical Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- There is no traditional "order book" system like government tenders; orders vary with oil and gas cycles.
- Business depends on delivering value as per client needs, with a focus on sustainable solutions.
- Once a well starts production, work is generally perennial and cannot be stopped abruptly.
- The company experiences fluctuations due to weather and operational cycles but maintains steady demand.
- Strong ongoing order flow is indicated, with existing expanded capacities being utilized (~63% utilized recently).
2 more points from Fineotex Chemical Ltd's call on order book
Create a free account to keep reading this call
Fineotex Chemical Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹314 Cr, net profit ₹44 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fineotex Chem's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fineotex Chemical Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fineotex Chemical Ltd Q1 FY27 results?
Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. Fineotex Chemicals anticipates strong revenue and profit growth driven by expanded Texas facility capacity and healthy demand in the U.S.
What is Fineotex Chemical Ltd share price analysis?
Fineotex Chemical Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 54.5 with a market cap of ₹6,667 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fineotex Chemical Ltd planning capital expenditure?
Fineotex Chemicals invested significantly in expanding its Texas facility, adding 69,000 MTPA capacity, increasing total capacity to 268,000 MTPA, enhancing ability to serve larger customer contracts and drive growth.
Keep Fineotex Chemical Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.